Advertisement







Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:1619-1626, doi:10.1016/j.jacc.2009.04.097
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Terrovitis, J.
Right arrow Articles by Marbán, E.
PubMed
Right arrow Articles by Terrovitis, J.
Right arrow Articles by Marbán, E.
Related Collections
Right arrowRelated Articles

PRE-CLINICAL RESEARCH

Noninvasive Quantification and Optimization of Acute Cell Retention by In Vivo Positron Emission Tomography After Intramyocardial Cardiac-Derived Stem Cell Delivery

John Terrovitis, MD*, Riikka Lautamäki, MD, PhD§, Michael Bonios, MD{dagger}, James Fox, BS||, James M. Engles, MS, MBA§, Jianhua Yu, BS||, Michelle K. Leppo, BS{dagger}, Martin G. Pomper, MD, PhD||, Richard L. Wahl, MD§, Jurgen Seidel, PhD{ddagger}, Benjamin M. Tsui, PhD||, Frank M. Bengel, MD§, M. Roselle Abraham, MD{dagger} and Eduardo Marbán, MD, PhD*,*

* The Heart Institute, Cedars Sinai Medical Center, Los Angeles, California
{dagger} Department of Cardiology, Johns Hopkins University, Baltimore, Maryland
{ddagger} Department of Diagnostic Imaging Physics, Johns Hopkins University, Baltimore, Maryland
§ Department of Nuclear Medicine, Johns Hopkins University, Baltimore, Maryland
|| Department of Radiology, Johns Hopkins University, Baltimore, Maryland

Manuscript received January 2, 2009; revised manuscript received March 16, 2009, accepted April 13, 2009.

* Reprint requests and correspondence: Dr. Eduardo Marbán, Director, The Heart Institute, Cedars Sinai Medical Center, 8700 Beverly Boulevard, 1090 Davis Building, Los Angeles, California 90048 (Email: Eduardo.Marban{at}csmc.edu).

Objectives: The aim of this study was to quantify acute myocardial retention of cardiac-derived stem cells (CDCs) and evaluate different delivery methods with positron emission tomography (PET).

Background: Success of stem cell transplantation for cardiac regeneration is partially limited by low retention/engraftment of the delivered cells. A clinically applicable method for accurate quantification of cell retention would enable optimization of cell delivery.

Methods: The CDCs were derived from syngeneic, male Wistar Kyoto (WK) rats labeled with [18F]-fluoro-deoxy-glucose (18FDG) and injected intramyocardially into the ischemic region of female WK rats after permanent left coronary artery ligation. The effects of fibrin glue (FG), bradycardia (adenosine), and cardiac arrest were examined. Imaging with 18FDG PET was performed for quantification of cell retention. Quantitative polymerase chain reaction (PCR) for the male-specific SRY gene was performed to validate the PET results.

Results: Myocardial retention of cells suspended in phosphate-buffered saline 1 h after delivery was 17.6 ± 11.5% by PCR and 17.8 ± 7.3% by PET. When CDCs were injected immediately after induction of cardiac arrest, retention was increased to 75.6 ± 18.6%. Adenosine slowed the ventricular rate and doubled CDC retention (35.4 ± 5.3%). A similar increase in CDC retention was observed after epicardial application of FG at the injection site (37.5 ± 8.2%). The PCR revealed a significant increase in 3-week cell engraftment in the FG animals (22.1 ± 18.6% and 5.3 ± 3.1%, for FG and phosphate-buffered saline, respectively).

Conclusions: In vivo PET permits accurate measurement of CDC retention early after intramyocardial delivery. Sealing injection sites with FG or lowering ventricular rate by adenosine might be clinically translatable methods for improving stem cell engraftment in a beating heart.

Key Words: adenosine • cardiac stem cells • fibrin glue • PET

Abbreviations and Acronyms
  18FDG = [18F]-fluoro-deoxy-glucose
  BDM = 2,3-butanedione-2-monoxime
  CDC = cardiac-derived stem cells
  CT = computed tomography
  FAC = fractional area change
  FG = fibrin glue
  MI = myocardial infarction
  PBS = phosphate-buffered saline
  PCR = polymerase chain reaction
  PET = positron emission tomography
  qPCR = quantitative polymerase chain reaction
  WKY = Wistar Kyoto


Related Articles

Tracking Cell Fate With Noninvasive Imaging
Gary S. Feigenbaum, Louis Lemberg, and Joshua M. Hare
J. Am. Coll. Cardiol. 2009 54: 1627-1628. [Full Text] [PDF]

Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A25. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al.
Highlights of the Year in JACC 2009
J. Am. Coll. Cardiol., January 26, 2010; 55(4): 380 - 407.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. S. Feigenbaum, L. Lemberg, and J. M. Hare
Tracking cell fate with noninvasive imaging.
J. Am. Coll. Cardiol., October 20, 2009; 54(17): 1627 - 1628.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement